PTPN11 and thyroid gland disorder: Future work should aim at the development of SHP2-targeted contrast agents with clinical grade and much efforts need to be made to promote the clinical translation of ultrasound molecular imaging technique, which could improve the diagnostic accuracy of thyroid lesions by ultrasonography.